Efficacy of Rifampicin and Isoniazid in Cutaneous Leishmaniasis
- 1 January 1987
- journal article
- clinical trial
- Published by Wiley in International Journal of Dermatology
- Vol. 26 (1) , 55-59
- https://doi.org/10.1111/j.1365-4362.1987.tb04578.x
Abstract
Thirty-nine patients with cutaneous leishmaniasis caused by Leishmania major were treated with rifampicin alone or in combination with isoniazid. No significant difference was found between these two therapeutic regimens, and about half of the patients were cured 2 months from the beginning of treatment. A review of rifampicin in cutaneous leishmaniasis is attached.Keywords
This publication has 14 references indexed in Scilit:
- An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovaniJournal of Antimicrobial Chemotherapy, 1984
- The effect of ketoconazole and a combination of rifampicin/amphotericin B on cutaneous leishmaniasis in laboratory miceTransactions of the Royal Society of Tropical Medicine and Hygiene, 1984
- Therapeutic Effect of Rifampicin and Isoniazid against Leishmania tropica majorInternational Journal of Dermatology, 1983
- Rifampicin Treatment of Cutaneous LeishmaniasisInternational Journal of Dermatology, 1982
- POTENTIATING ACTION OF RIFAMPICIN AND ISONIAZID AGAINST LEISHMANIA MEXICANA AMAZONENSISThe Lancet, 1981
- Failure of rifampin therapy to cure cutaneous leishmaniaisArchives of Dermatology, 1980
- Leishmaniasis: A Case History and Treatment Failure With RifampinArchives of Dermatology, 1980
- Leishmaniasis: a case history and treatment failure with rifampinArchives of Dermatology, 1980
- Rifampin in LeishmaniasisArchives of Dermatology, 1977
- Kutane Leishmaniose: autochthoner Fall in der SchweizDermatology, 1976